• Home
  • Illinois News
  • Illinois Politics
  • US Politics
  • US NEWS
  • America First
  • Opinion
  • World News
  • Second Amendment
Sunday, July 13, 2025
Illinois Review
  • Login
  • Register
  • Home
  • Illinois News
  • Illinois Politics
  • US Politics
  • US NEWS
  • America First
  • Opinion
  • World News
  • Second Amendment
No Result
View All Result
  • Home
  • Illinois News
  • Illinois Politics
  • US Politics
  • US NEWS
  • America First
  • Opinion
  • World News
  • Second Amendment
No Result
View All Result
Illinois Review
No Result
View All Result
Home Illinois News

How to Make New Drugs More Affordable

Illinois Review by Illinois Review
January 9, 2017
in Illinois News
Reading Time: 2 mins read
A A
0
26
SHARES
432
VIEWS
Share on FacebookShare on Twitter

Pills

You might also like

Opinion: The IL GOP Belongs to the People — Not to Power-Hungry Insiders

Economos: Illinois’ Pension Crisis – A Tale of Mismanagement

Mayor Johnson: Chicago ‘Police Dept. Will Not Ever Cooperate with ICE’

Want lower drug prices? Get more competition in drugs. Devon Herrick writes: “A little over a decade ago, many in the public health community began asserting that follow-on or “me-too” drugs offer little added benefit and are a waste of resources that would be better spent to research novel drug therapies. The FDA seemingly took this criticism to heart; in recent years it has fast-tracked approval of new, first-in-class drugs thought to show promise. Yet, as with any new drug, a “me-to drug” could take up to 15 years to research, develop and obtain FDA approval. A drug that comes to market one year after a first-in-class drug could have been first-in-class if that research and development team had been just a little faster. Thus, when the FDA discourages me-too drugs it is discriminating against every competitor that did not cross the finish line first. As a result, approvals for expensive drugs to treat rare diseases are at a historic high while approvals of me-too drugs are down. This limits competition within drug classes, leading to higher prices, and limits patient choices—something the FDA is just beginning to acknowledge.”

More at National Center for Policy Analysis

Related

Tags: Illinois Review
Share10Tweet7
Previous Post

Chicago area group withdraws from Trump Inaugural Parade, another resists pressure

Next Post

Why the Repeal of ObamaCare Means a Giant Tax Cut for the Middle Class

Illinois Review

Illinois Review

Recommended For You

Opinion: The IL GOP Belongs to the People — Not to Power-Hungry Insiders

by Jacqueline Garretson
July 11, 2025
0
Opinion: The IL GOP Belongs to the People — Not to Power-Hungry Insiders

By Jacqueline Garretson, Opinion ContributorA few months ago, I had the opportunity to speak on a podcast where I shared my personal journey in politics, how I became...

Read moreDetails

Economos: Illinois’ Pension Crisis – A Tale of Mismanagement

by James P. Economos, DDS
July 8, 2025
0
Economos: Illinois’ Pension Crisis – A Tale of Mismanagement

By James P. Economos, DDS, Opinion Contributor There’s been constant debate over Illinois' pension system – and for good reason. It remains chronically underfunded and plagued with issues...

Read moreDetails

Mayor Johnson: Chicago ‘Police Dept. Will Not Ever Cooperate with ICE’

by Illinois Review
July 8, 2025
0
Mayor Johnson: Chicago ‘Police Dept. Will Not Ever Cooperate with ICE’

By Illinois ReviewAt a Tuesday morning press conference at Chicago City Hall, Mayor Brandon Johnson — whose approval rating hovers around six percent — reiterated that local law...

Read moreDetails

Chicago AM560 Axes Local Morning Radio Personality Amy Jacobson, Keeps Florida-based Host in Cost-Cutting Move

by Illinois Review
July 1, 2025
0
Chicago AM560 Axes Local Morning Radio Personality Amy Jacobson, Keeps Florida-based Host in Cost-Cutting Move

By Illinois ReviewIn a shocking cost-cutting move Tuesday, Chicago’s AM560 The Answer terminated longtime morning host Amy Jacobson, as the struggling conservative station grapples with declining relevance –...

Read moreDetails

JB Pritzker Receives 2% in Presidential Poll, Ranks Lowest in Minority Support Among Democrats

by Illinois Review
June 30, 2025
0
JB Pritzker Receives 2% in Presidential Poll, Ranks Lowest in Minority Support Among Democrats

By Illinois ReviewIn one of the first nationwide hypothetical polls for the 2028 Democratic presidential primary, Illinois Governor and billionaire JB Pritzker ranks at the bottom, receiving the...

Read moreDetails
Next Post

Why the Repeal of ObamaCare Means a Giant Tax Cut for the Middle Class

Please login to join discussion

Best Dental Group

Related News

IL Freedom Caucus calls on Lurie Children’s Hospital to cease gender services for kids

October 27, 2022

Beckman: Is the Brigham Young University racial slur controversy another hoax?

October 27, 2022

Salvi polling shows closer race

October 27, 2022

Browse by Category

  • America First
  • Education
  • Faith & Family
  • Foreign Policy
  • Health Care
  • Illinois News
  • Illinois Politics
  • Opinion
  • Science
  • Second Amendment
  • TRENDING
  • US NEWS
  • US Politics
  • World News
Illinois Review

© 2024 llinois Review LLC Editor in Chief Mark Vargas Publisher Thomas McCullagh Chief Counsel Scott Kaspar

Navigate Site

  • Checkout
  • Home
  • Home – mobile
  • Login/Register
  • Login/Register
  • My account
  • My Account-
  • My Account- – mobile

Follow Us

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Illinois News
  • Illinois Politics
  • US Politics
  • Health Care
  • US NEWS
  • America First
  • Opinion
  • TRENDING
  • Education
  • Foreign Policy
  • Second Amendment
  • Faith & Family
  • Science
  • World News

© 2024 llinois Review LLC Editor in Chief Mark Vargas Publisher Thomas McCullagh Chief Counsel Scott Kaspar

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?